Ian Mortimer - Net Worth and Insider Trading
Ian Mortimer Net Worth
The estimated net worth of Ian Mortimer is at least $2 Million dollars as of 2026-09-14. Ian Mortimer is the PRESIDENT & CEO of Xenon Pharmaceuticals Inc and owns about 34,223 shares of Xenon Pharmaceuticals Inc (XENE) stock worth over $2 Million. Details can be seen in Ian Mortimer's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Ian Mortimer has not made any transactions after 2026-03-13 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Ian Mortimer
Ian Mortimer Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Ian Mortimer owns 1 companies in total, including Xenon Pharmaceuticals Inc (XENE) .
Click here to see the complete history of Ian Mortimer’s form 4 insider trades.
Insider Ownership Summary of Ian Mortimer
| Ticker | Company | Transaction Date | Type of Owner |
|---|---|---|---|
| XENE | Xenon Pharmaceuticals Inc | 2026-03-13 | director & PRESIDENT & CEO |
Ian Mortimer Latest Holdings Summary
Ian Mortimer currently owns a total of 1 stock. Ian Mortimer owns 34,223 shares of Xenon Pharmaceuticals Inc (XENE) as of March 13, 2026, with a value of $2 Million.
Latest Holdings of Ian Mortimer
| Ticker | Company | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| XENE | Xenon Pharmaceuticals Inc | 2026-03-13 | 34,223 | 58.65 | 2,007,179 |
Holding Weightings of Ian Mortimer
Ian Mortimer Form 4 Trading Tracker
According to the SEC Form 4 filings, Ian Mortimer has made a total of 8 transactions in Xenon Pharmaceuticals Inc (XENE) over the past 5 years, including 0 buys and 8 sells. The most-recent trade in Xenon Pharmaceuticals Inc is the sale of 7,308 shares on March 13, 2026, which brought Ian Mortimer around $403,621.
Insider Trading History of Ian Mortimer
* The information on this page (including Insider Trading Shares, Share Changes, Cost, etc.) is sourced exclusively from Form 4 filings and does not incorporate any data from 13F or 13D/G filings. As a result, it may differ from the values shown on the Guru page.
- 1
Ian Mortimer Trading Performance
GuruFocus tracks the stock performance after each of Ian Mortimer's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Ian Mortimer is 6.69%. GuruFocus also compares Ian Mortimer's trading performance to market benchmark return within the same time period. The performance of stocks bought by Ian Mortimer within 3 months outperforms 1 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Ian Mortimer's insider trading performs compared to the benchmark.
Performance of Ian Mortimer
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 13.79 | | | | | |
| Relative Return to S&P 500(%) | 9.94 | | | | | |
Ian Mortimer Ownership Network
Ownership Network List of Ian Mortimer
Ownership Network Relation of Ian Mortimer
Ian Mortimer Owned Company Details
What does Xenon Pharmaceuticals Inc do?
Who are the key executives at Xenon Pharmaceuticals Inc?
Ian Mortimer is the director & PRESIDENT & CEO of Xenon Pharmaceuticals Inc. Other key executives at Xenon Pharmaceuticals Inc include Chief Medical Officer Christopher John Kenney , Chief Legal Officer Andrea Difabio , and Chief Financial Officer Thomas Patrick Kelly .
Xenon Pharmaceuticals Inc (XENE) Insider Trades Summary
Over the past 18 months, Ian Mortimer made 6 insider transaction in Xenon Pharmaceuticals Inc (XENE) with a net sale of 378,879. Other recent insider transactions involving Xenon Pharmaceuticals Inc (XENE) include a net sale of 11,249 shares made by Christopher John Kenney , a net sale of 10,003 shares made by Steven Gannon , and a net sale of 3,949 shares made by Andrea Difabio .
In summary, during the past 3 months, insiders sold 17,068 shares of Xenon Pharmaceuticals Inc (XENE) in total and bought 0 shares, with a net sale of 17,068 shares. During the past 18 months, 406,592 shares of Xenon Pharmaceuticals Inc (XENE) were sold and 0 shares were bought by its insiders, resulting in a net sale of 406,592 shares.
Xenon Pharmaceuticals Inc (XENE)'s detailed insider trading history can be found in Insider Trading Tracker table.
Xenon Pharmaceuticals Inc Insider Transactions
Ian Mortimer Mailing Address
Above is the net worth, insider trading, and ownership report for Ian Mortimer. Based on the public information released on the U.S. Securities and Exchange Commission (SEC) website, Ian Mortimer's mailing address is: Burnaby.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
